Cardiovascular Diabetology

JANUARY 19, 2024

Diabetes mellitus (DM) is associated with a worse prognosis in patients with heart failure. Our aim was to analyze the clinical and imaging features of patients with DM and their association with outcomes in c.

Diabetes 95

Diabetes Outcomes Heart Failure Cardiomyopathy 95

The New England Journal of Medicine

MARCH 28, 2025

Among participants with type 2 diabetes and cardiovascular disease, chronic kidney disease, or both, oral semaglutide (14 mg) was associated with a lower risk of cardiovascular events than placebo after 4 years of follow-up.

Diabetes 75

Diabetes Kidney Disease Cardiovascular Disease Outcomes 75

Med Page Today

DECEMBER 12, 2023

(MedPage Today) -- Adding metformin to insulin treatment for pregnant women with preexisting type 2 or gestational diabetes did not reduce composite neonatal adverse outcomes, according to the randomized MOMPOD trial. The composite outcome -.

Diabetes 105

Diabetes Outcomes 105

DAIC

JULY 10, 2024

Findings from an observational analysis of ARISE-HF trial participants, newly-published in the Journal of the American College of Cardiology, JACC, shed light on the racial and ethnic disparities in diabetic cardiomyopathy (DbCM), which researchers note may have the potential to inform clinical practice, interventions, and policies.

Cardiomyopathy 113

Cardiomyopathy Diabetes Health Disparities Exercise 113

Cardiovascular Diabetology

JANUARY 27, 2024

Underweight imposes significant burden on cardiovascular outcomes in patients with diabetes mellitus. However, less is known about the impact of serial change in body weight status measured as body mass index.

Cardiac Arrest 116

Cardiac Arrest Diabetes Outcomes Research 116

Cardiovascular Diabetology

JULY 17, 2024

The beneficial effects of fenofibrate on atherosclerotic cardiovascular disease (ASCVD) outcomes in patients with diabetes and statin treatment are unclear. We investigated the effects of fenofibrate on all-ca.

Diabetes 105

Diabetes Cardiovascular Disease Outcomes Research 105

HCPLive

MARCH 5, 2024

Initiation of SGLT2 inhibitors reduced the risk of composite anemia outcomes, compared with GLP-1 RA, among patients with type 2 diabetes and CKD.

Diabetes 105

Diabetes Outcomes 105

Med Page Today

NOVEMBER 16, 2024

(MedPage Today) -- CHICAGO -- The cardiovascular outcome benefit of a tighter systolic blood pressure target was affirmed in patients with type 2 diabetes in the randomized BPROAD trial from China. A target of less than 120 mm Hg reduced a composite.

Blood Pressure 97

Blood Pressure Diabetes Outcomes 97

HCPLive

DECEMBER 19, 2023

While the ACT program did not benefit patients in the study’s primary outcome measure, it did lead to some other benefits for those with type 1 diabetes.

Diabetes 105

Diabetes Outcomes 105

CardiacWire

MARCH 12, 2025

One of the biggest risk factors for patients who need coronary revascularization is diabetes, and a new study in JAMA suggests CABG could be a better option than FFR-guided PCI when it comes to long term outcomes for these patients. Patients with T2D who underwent PCI had a 44% higher MACCE risk than those who underwent CABG.

Diabetes 59

Diabetes Stent Stents Risk Factors 59

European Journal of Heart Failure

OCTOBER 9, 2024

Cardiovascular outcomes with exenatide in type 2 diabetes (T2D) according to left ventricular ejection fraction (LVEF): the EXSCEL trial. Aims Glucagon-like peptide-1 receptor agonists reduce major adverse cardiovascular events (MACE) and cardiovascular mortality in people with type 2 diabetes (T2D).

Diabetes 75

Diabetes Outcomes Heart Failure Obesity 75

Circulation

FEBRUARY 12, 2024

BACKGROUND:Cardiovascular disease is a major cause of morbidity and mortality in patients with type 2 diabetes. The effects of glucose-lowering medications on cardiovascular outcomes in individuals with type 2 diabetes and low cardiovascular risk are unclear. years, type 2 diabetes duration of 4.0±2.7

Diabetes 80

Diabetes Outcomes Myocardial Infarction Heart Failure 80

HCPLive

FEBRUARY 20, 2024

Viral Shah, MD, joins Diabetes Dialogue to discuss a recent study examining associations between time in range and other advanced CGM metrics with diabetic retinopathy and the implications for use in predicting other microvascular outcomes.

Diabetes 64

Diabetes Outcomes 64

The New England Journal of Medicine

MARCH 26, 2025

In this trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-pressure target of less than 120 mm Hg than with a target of less than 140 mm Hg.

Blood Pressure 75

Blood Pressure Diabetes Outcomes 75

Cardiometabolic Health Congress

JUNE 14, 2024

Recent over-the-counter (OTC) approvals for CGM systems are transforming diabetes management and lifestyle management for those without diabetes, making this an exciting time for healthcare professionals and their patients. These enhancements offer benefits beyond diabetes management, including support for women across the lifespan.

Technology 105

Technology Diabetes Outcomes Innovation 105

Cardiovascular Diabetology

FEBRUARY 27, 2024

Non-alcoholic fatty liver disease (NAFLD), identified by the Fatty Liver Index (FLI), is associated with increased mortality and cardiovascular (CV) outcomes. Whether this also applies to type 1 diabetes (T1D).

Diabetes 110

Diabetes Risk Factors Outcomes Research 110

Cardiovascular Diabetology

AUGUST 6, 2024

Objective To explore trends in prognosis and use of glucose-lowering drugs (GLD) in patients with diabetes and coronary artery disease (CAD). Research design and methods All patients with diabetes and CAD undergoing a coronary angiography between 2010 and 2021 according to the Swedish Angiography and Angioplasty Registry were included.

Coronary Artery Disease 98

Coronary Artery Disease Diabetes Myocardial Infarction Heart Failure 98

Dr. Paddy Barrett

NOVEMBER 8, 2024

“Statins cause diabetes” This one is true. In truth, it is really those who are pre-diabetic who likely pull forward their diagnosis by about five days. But they do not magically take someone who is insulin-sensitive to full-blown type 2 diabetes overnight. But the devil is in the detail.

Cholesterol 130

Cholesterol Plaque Heart attacks Heart Attack 130

Journal of the American Heart Association

DECEMBER 24, 2024

The primary outcome was atherothrombotic major adverse cardiovascular events as a composite outcome of cardiovascular mortality, nonfatal stroke, and nonfatal myocardial infarction. Patients were propensity matched in a 1:1 ratio using a caliper distance of 0.2 without replacement.

Myocardial Infarction 75

Myocardial Infarction Diabetes Outcomes Stroke 75

HCPLive

DECEMBER 19, 2023

Addressing a lack of quantitative data on AID, this study used validated measures in a real-world setting to corroborate the psychosocial benefits seen in prior qualitative research.

Diabetes 105

Diabetes Outcomes Research 105

HCPLive

MARCH 26, 2024

A study in China identified a negative and non-linear relationship between hemoglobin levels and a renal composite end point in patients with DKD.

Kidney Disease 98

Kidney Disease Diabetes Outcomes 98

HCPLive

JULY 24, 2024

A database analysis linked semaglutide use to notable reductions in the rates of diabetic macular edema and vitreous hemorrhage in diabetic retinopathy.

Diabetes 59

Diabetes Hemorrhage Outcomes 59

HCPLive

OCTOBER 4, 2024

An EADV 2024 study suggests dupilumab use during pregnancy is generally safe and may lower risks of preterm labor, gestational hypertension, and diabetes.

Diabetes 110

Diabetes Outcomes Hypertension 110

Frontiers in Cardiovascular Medicine

FEBRUARY 24, 2025

Hypertension and diabetes were the two most common risk factors identified. Despite the fact that percutaneous coronary intervention is the standard of care in one subset of acute coronary syndrome, significant number of patients were treated medically due to the limited service in the setting. were male, with the average age of 56.313.5

Hospital 98

Hospital Myocardial Infarction Chest Pain Electrocardiogram 98

American College of Cardiology

APRIL 26, 2024

Since limb events are major drivers of morbidity in diabetic patients with peripheral (PAD) and coronary artery disease (CAD), does the addition of ticagrelor to background therapy of aspirin improve limb events?

Diabetes 62

Diabetes Coronary Artery Disease Outcomes Article 62

Cardiometabolic Health Congress

JANUARY 8, 2025

Last month, the 2025 American Diabetes Association (ADA) guidelines were introduced, providing updates for diagnosing and managing diabetes and prediabetes. This ensures patients have contingency plans to maintain effective diabetes management during periods of unavailability.

Diabetes 59

Diabetes Outpatient Inpatient Outcomes 59

Cardiometabolic Health Congress

JANUARY 30, 2024

As an expert on metabolic control and type 2 diabetes (T2D), Dr. Hallberg once gave a TedTalk titled Reversing Type 2 diabetes starts with ignoring the guidelines , which quickly accumulated 8.6 Research now suggests the potential for diabetes reversal through other means that have only recently been embraced in official guidelines.

Webinar 105

Webinar Diabetes Education Diet 105

NEJM Journal Watch - Cardiology

APRIL 30, 2024

The highly selective aldose reductase inhibitor AT-001 did not improve exercise capacity in a randomized trial.

Cardiomyopathy 81

Cardiomyopathy Diabetes Exercise Outcomes 81

Medical Xpress - Cardiology

OCTOBER 25, 2024

Sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with type 2 diabetes, but it is unclear whether their effects differ based on patients' age.

Outcomes 74

Outcomes Diabetes 74

DAIC

MARCH 14, 2025

Simultaneous pancreas-kidney (SPK) transplants are known to improve the quality of life and long-term survival of patients with insulin dependent diabetes and advanced renal disease. I have witnessed firsthand the significant benefits for patients with diabetes and kidney failure of receiving a pancreas and kidney transplant.

Heart Transplant 87

Heart Transplant Transplant Pediatrics Quality of Life 87

HCPLive

MARCH 31, 2025

Justin Mark, MD, discusses an analysis of the FIGHT trial looking at racial and ethnic differences in heart failure outcomes.

Heart Failure 59

Heart Failure Outcomes Diabetes 59

Dr. Paddy Barrett

JANUARY 2, 2025

The Defining Risk module includes lessons on: Defining Metabolic Health Cholesterol Principles Understanding Your Cholesterol Panel Advanced Cholesterol Testing Lipoprotein (a) - Lp(a) Insulin Resistance Metabolic Syndrome Pre-Diabetes & Diabetes Assessing Visceral Fat How To Measure Fitness The Importance of Muscle Metrics.

Cholesterol 83

Cholesterol Heart Disease Blood Pressure Coronary Angiogram 83

Cardiovascular Diabetology

MARCH 25, 2025

Understanding the relationship between serum ferritin levels and cardiovascular outcomes in type 2 diabetes is crucial for improving risk stratification and guiding therapeutic interventions aimed at preventin.

BMI 59

BMI Diabetes Cardiovascular Disease Outcomes 59

Cardiovascular Diabetology

JUNE 6, 2024

Sodium glucose cotransporter 2 (SGLT2) inhibitors significantly improve cardiovascular outcomes in diabetic patients; however, the mechanism is unclear. We hypothesized that dapagliflozin improves cardiac outc.

Diabetes 64

Diabetes Heart Failure Outcomes Research 64

Frontiers in Cardiovascular Medicine

JANUARY 14, 2024

Background The objective of this study was to investigate the differences in presenting symptoms between patients with and without diabetes being diagnosed with an acute myocardial infarction (AMI). Results Patients with diabetes had significantly less frequent typical pain symptoms, including typical chest pain.

Myocardial Infarction 64

Myocardial Infarction Diabetes Chest Pain Risk Factors 64

Circulation

MARCH 11, 2024

BACKGROUND:Diabetes may be associated with differential outcomes in patients undergoing left main coronary revascularization with percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). Patients were categorized by diabetes status. PintHR=0.87) diabetes. and 9.9%) compared with those without (2.1%

Coronary Artery Bypass Graft 81

Coronary Artery Bypass Graft Diabetes Coronary Artery Disease Stent 81

DAIC

MARCH 26, 2025

2 Most are balancing multiple comorbidities, such as obesity, diabetes, hypertension and chronic kidney disease (CKD). 2 Most are balancing multiple comorbidities, such as obesity, diabetes, hypertension and chronic kidney disease (CKD). 4 Approximately 6.7 million adults in the U.S. 7 Of these patients, about 55% have a LVEF 40%.

Heart Failure 52

Heart Failure Preserved Ejection Fraction Kidney Disease ACE Inhibitor 52